Lexicon Pharmaceuticals Inc. (Nasdaq: LXRX) said March 28 it will exclusively license its drug candidate LX9581 to Danish ...

As U.S. President Donald Trump threatens a new round of tariffs as part of an onshoring push, Chinese President Xi Jinping is ...

The ongoing investigation by Wyden and his Democratic compatriots from the Finance Committee has pointed the finger at ...

Corvus Pharmaceuticals suffered lately, especially after it announced in December 2024 its early AD data. Check out why I ...

WALTHAM, Mass., March 28, 2025 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (Nasdaq: CKPT), a commercial-stage immunotherapy and targeted oncology company, today announced ...

German airline Lufthansa's air freight business said on Friday it is experiencing an increase in demand for pharmaceutical ...

FY 2024 net product revenues increased 140% to $607.6 thousand.FY 2024 gross profit increased $443.8 thousand from ($221 thousand) to $222.8 ...

AG Kwame Raoul files for approval of a $39.1 million settlement with Apotex Inc. over drug price inflation claims.

Bureaucracy and delays are pushing clinical trials away from Europe, with Asia and the United States taking the lead.

Indian pharma companies may stand to gain market share due to the potential impact of US tariffs, according to a JPMorgan ...

India has emerged as a growing player in the illicit fentanyl trade, a new US intelligence report says, a designation likely to raise alarm in New Delhi as President Donald Trump wields tariffs on ...

Japanese drug firm Chugai Pharmaceutical has established competitive advantages due to its alliance with majority shareholder Roche as well as its internal research and development engine. While ...